Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.

Sellar RS., Mehra V., Fox TA., Grigg A., Kulasekararaj A., Sarma A., de Lavallade H., McLornan D., Raj K., Mufti GJ., Pagliuca A., Mackinnon S., Chakraverty R., Fielding AK., Carpenter B., Kottaridis PD., Khwaja A., Peggs KS., Thomson KJ., Morris EC., Potter VT.

DOI

10.1111/bjh.16136

Type

Journal article

Publication Date

2019-10-01T00:00:00+00:00

Volume

187

Pages

e20 - e24

Keywords

T-cell deplete conditioning, acute myeloid leukaemia, alemtuzumab, allogeneic stem cell transplant, Adult, Aged, Alemtuzumab, Busulfan, Female, Humans, Leukemia, Myeloid, Acute, Lymphocyte Depletion, Male, Melphalan, Middle Aged, Retrospective Studies, Survival Analysis, Transplantation Conditioning, Unrelated Donors, Young Adult

Permalink More information Close